Treffer 1 - 6 von 6 für Suche 'Holder, Jenessa', Suchdauer: 0,34s Treffer weiter einschränken
  1. 1
    Neurologic immune related adverse events (irAEs) in patients with metastatic solid tumors treated with immune checkpoint inhibitors: a single institution retrospective analysis (N6.001)

    Neurologic immune related adverse events (irAEs) in patients with metastatic solid tumors treated with immune checkpoint inhibitors: a single institution retrospective analysis (N6... von Malani, Rachna, Haggiagi, Aya, Holder, Jenessa, Shames, Yelena, Briggs, Samuel, Callahan, Margaret, Santomasso, Bianca

    Veröffentlicht in Neurology

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    NTOX-14. THE DEVELOPMENT OF NEUROLOGIC IMMUNE RELATED ADVERSE EVENTS (irAEs) IN PATIENTS WITH METASTATIC SOLID TUMORS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS

    NTOX-14. THE DEVELOPMENT OF NEUROLOGIC IMMUNE RELATED ADVERSE EVENTS (irAEs) IN PATIENTS WITH METASTATIC SOLID TUMORS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A SINGLE INSTITUTIO... von Malani, Rachna, Haggiagi, Aya, Holder, Jenessa, Shames, Yelena, Briggs, Samuel, Santomasso, Bianca, Callahan, Margaret


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Neurologic immune related adverse events (irAEs) in patients treated with immune checkpoint blockade

    Neurologic immune related adverse events (irAEs) in patients treated with immune checkpoint blockade von Santomasso, Bianca, Haggiagi, Aya, Malani, Rachna, Maher, Colleen Anne, Holder, Jenessa N., Shames, Yelena, Wilcox, Jessica, Flynn, Jessica, Briggs, Samuel, Panageas, Katherine, Callahan, Margaret K.

    Veröffentlicht in Journal of clinical oncology

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    Interleukin-6 (IL-6) Blockade with Siltuximab Peri-Autologous Hematopoietic Stem Cell Transplantation (AHCT) May Reduce Symptom Burden by Altering the Cytokine Milieu in Older Patients with Multiple Myeloma (MM)

    Interleukin-6 (IL-6) Blockade with Siltuximab Peri-Autologous Hematopoietic Stem Cell Transplantation (AHCT) May Reduce Symptom Burden by Altering the Cytokine Milieu in Older Pati... von Shah, Gunjan, Holder, Jenessa, Cho, Sun, Murata, Kazunori, Devlin, Sean, Hoover, Elizabeth, Chung, David, Dahi, Parastoo, Lahoud, Oscar, Scordo, Michael, Landau, Heather, Giralt, Sergio


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  5. 5
    Improved Quality of Life with Interleukin-6 (IL-6) Blockade with Siltuximab Peri-Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Older Patients with Multiple Myeloma (MM)

    Improved Quality of Life with Interleukin-6 (IL-6) Blockade with Siltuximab Peri-Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Older Patients with Multiple Myeloma (... von Shah, Gunjan L., Murata, Kazunori, Holder, Jenessa, Marcello, Leeann, Cho, Sun, Hoover, Elizabeth, Chung, David J., Dahi, Parastoo B., Lahoud, Oscar Boutros, Scordo, Michael, Landau, Heather J, Giralt, Sergio A.


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  6. 6
    Reducing Symptom Burden in Older Patients with Multiple Myeloma (MM) Using Interleukin-6 (IL-6) Blockage Peri-Autologous Hematopoietic Stem Cell Transplantation (AHCT)

    Reducing Symptom Burden in Older Patients with Multiple Myeloma (MM) Using Interleukin-6 (IL-6) Blockage Peri-Autologous Hematopoietic Stem Cell Transplantation (AHCT) von Shah, Gunjan L., Kosuri, Satyajit, Holder, Jenessa, Hoover, Elizabeth, Chung, David J., Dahi, Parastoo B, Scordo, Michael, Landau, Heather, Giralt, Sergio A.


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: